AI in drug discovery
AI in drug discovery is the application of artificial intelligence, machine learning, and deep learning across the pharmaceutical pipeline to identify drug targets, design new molecules, predict protein…
Drug Discovery
Explore Drug Discovery through related topics and the articles other pages reference most.
Explore articles
Browse subtopics: Healthcare AI
Articles that also belong to these categories. Counts cover all of Drug Discovery.
Showing 1-14 of 14 articles
Coefficient Bio
Coefficient Bio was a stealth-stage biotechnology and artificial-intelligence startup that, according to multiple press reports, was acquired by Anthropic in an all-stock deal reported at just over $400…
ESM3
ESM3 (Evolutionary Scale Modeling 3) is a frontier multimodal generative language model for biology, released by EvolutionaryScale on June 25, 2024, that was the first model to reason jointly over the…
EvolutionaryScale
EvolutionaryScale is an American artificial intelligence company that builds frontier generative models for biology, best known for ESM3, a multimodal generative protein language model that can reason over and…
Generate Biomedicines
Generate Biomedicines (styled "Generate:Biomedicines," and legally Generate Biomedicines, Inc.) is a clinical-stage biotechnology company that uses generative AI to design novel protein therapeutics, including…
Insilico Medicine
Insilico Medicine is a clinical-stage biotechnology company that uses generative AI to discover disease targets and design small-molecule drugs end to end.
IsoDDE
IsoDDE, short for Isomorphic Labs Drug Design Engine, is a unified computational drug design system developed by Isomorphic Labs, the Alphabet subsidiary spun out of Google DeepMind in 2021.
Isomorphic Labs
Isomorphic Labs is a London-based artificial intelligence company that designs small molecule and antibody drugs using deep learning models derived from the AlphaFold family of protein structure predictors.
Latent Labs
Latent Labs is a British and American artificial intelligence company building generative foundation models for protein and molecular design.
Nabla Bio
Nabla Bio is a Boston-based artificial intelligence biotechnology company that designs antibodies and other protein therapeutics computationally, an approach it calls generative protein design.
Recursion Pharmaceuticals
Recursion Pharmaceuticals (NASDAQ: RXRX) is a clinical-stage TechBio company in Salt Lake City, Utah
Rentosertib
Rentosertib is an investigational oral small-molecule inhibitor of TNIK (TRAF2- and NCK-interacting kinase) developed by Insilico Medicine for idiopathic pulmonary fibrosis (IPF)
Waypoint Bio
Waypoint Bio is an AI-native biotechnology company based in New York City that designs cell therapies for solid tumors by combining spatial biology with machine learning and in vivo pooled screening.
Xaira Therapeutics
Xaira Therapeutics is an American AI-driven drug discovery company based in South San Francisco, California, that launched publicly on April 23, 2024 with more than $1 billion in committed capital